SCHEMBL3425859

SCHEMBL3425859

O=C(O)C1C2CC(C1C(=O)O)C1C3CC(C(C(=O)O)C3C(=O)O)C21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.52
TDP1 Q9NUW8 2/20 0.52
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
ALDH1A1 P00352 1/20 0.41
SLC1A2 P43004 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAPK1 P28482 1/20 0.39
LMNA P02545 4/20 0.39
HTT P42858 1/20 0.39
TSHR P16473 3/20 0.38
PMP22 Q01453 2/20 0.38
KDM4E B2RXH2 2/20 0.38
APEX1 P27695 1/20 0.38
GMNN O75496 1/20 0.38
TFPI2 P48307 1/20 0.38
TP53 P04637 1/20 0.38
NFKB1 P19838 1/20 0.38
THPO P40225 1/20 0.38
CYP2D6 P10635 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29426398 0.97 POLB (0.50) POLBTDP1CYP1A2CYP2C19ALDH1A1
SCHEMBL16361417 0.94 POLB (0.48) POLBTDP1CYP1A2CYP2C19ALDH1A1
SCHEMBL23214101 0.92 POLB (0.46) POLBTDP1CYP1A2CYP2C19ALDH1A1
SCHEMBL16249737 0.91 POLB (0.50) POLBTDP1CYP1A2CYP2C19ALDH1A1
SCHEMBL13784510 0.87 POLB (0.43) POLBTDP1CYP1A2CYP2C19ALDH1A1
SCHEMBL432536 0.87 POLB (0.57) POLBTDP1CYP1A2CYP2C19ALDH1A1
SCHEMBL16249880 0.85 POLB (0.50) POLBTDP1CYP1A2CYP2C19ALDH1A1
SCHEMBL16249619 0.84 POLB (0.44) POLBTDP1CYP1A2CYP2C19ALDH1A1
SCHEMBL7531898 0.84 POLB (0.44) POLBTDP1CYP1A2CYP2C19ALDH1A1
SCHEMBL16249890 0.82 HSD11B1 (0.42) POLBTDP1CYP1A2CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208766-A1 POLYAMIC ACID SOLUTION COMPOSITION AND POLYIMIDE FILM UBE INDUSTRIES, LTD. (JP) 2018-07-26 US claimed
US-12479194-B2 Laminate TOYOBO CO., LTD. (JP) 2025-11-25 US disclosed
US-12472732-B2 Laminate, method for manufacturing laminate, and method for manufacturing flexible electronic device TOYOBO CO., LTD. (JP) 2025-11-18 US disclosed
US-12391813-B2 Layered body including inorganic substrate and polyamic acid cured product TOYOBO CO., LTD. (JP) 2025-08-19 US disclosed
CN-120059184-A Polyimide precursor composition, polyimide film, and polyimide film/substrate laminate UBE株式会社 2025-05-30 CN disclosed
CN-118139913-B Polyimide precursor composition, polyimide film, and polyimide film/substrate laminate UBE株式会社 2025-04-29 CN disclosed
WO-2025047667-A1 SHEET MATERIAL AND METHOD FOR PRODUCING SHEET MATERIAL 東洋紡株式会社 2025-03-06 WO disclosed
US-20250019508-A1 LAYERED BODY INCLUDING INORGANIC SUBSTRATE AND POLYAMIC ACID CURED PRODUCT TOYOBO CO., LTD. (JP) 2025-01-16 US disclosed
US-12172409-B2 Laminate of inorganic substrate/polymer film layer with attached protective film, laminate stack, laminate storage method, and laminate transport method TOYOBO CO., LTD. (JP) 2024-12-24 US disclosed
CN-119173585-A Polyimide precursor composition, polyimide film, and polyimide film/substrate laminate UBE株式会社 2024-12-20 CN disclosed
US-20150056367-A1 COMPOSITION FOR FORMING LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT SOKI CORPORATION (JP) 2015-02-26 US disclosed
US-20140378645-A1 LIQUID CRYSTAL ALIGNING AGENT WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2014-12-25 US disclosed
EP-2803672-A1 LIQUID CRYSTAL ALIGNING AGENT Wako Pure Chemical Industries, Ltd. (JP) 2014-11-19 EP disclosed
US-20140066571-A1 POLYIMIDE PRECURSOR AND POLYIMIDE UBE INDUSTRIES, LTD. (JP) 2014-03-06 US disclosed
CN-102333811-B Polyamic acid and polyimide, and method, composition and use for producing same MITSUI CHEMICALS INC 2013-07-17 CN disclosed
US-20130178597-A1 POLYIMIDE PRECURSOR, POLYIMIDE, AND MATERIALS TO BE USED IN PRODUCING SAME UBE INDUSTRIES, LTD. (JP) 2013-07-11 US disclosed
EP-2597111-A1 POLYIMIDE PRECURSOR, POLYIMIDE, AND MATERIALS TO BE USED IN PRODUCING SAME Ube Industries, Ltd. (JP) 2013-05-29 EP disclosed
US-20100304160-A1 POLYIMIDE COMPOSITE MATERIAL AND FILM THEREOF MITSUI CHEMICALS, INC. (JP) 2010-12-02 US disclosed
CN-101874078-A Polyimide-based composite material and film thereof MITSUI CHEMICALS INC 2010-10-27 CN disclosed
EP-2218754-A1 POLYIMIDE COMPOSITE MATERIAL AND FILM OF THE SAME Mitsui Chemicals, Inc. (JP) 2010-08-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378645-A1 LIQUID CRYSTAL ALIGNING AGENT CYP17A1, AUP1, NR5A1 POLB 846/4885TDP1 2030/4885CYP1A2 2859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.